I would expect that for each of the good news release a huge spike will happen due to the large among of short seller trying to cover their shorts. It's too bad that there are no statistics on CTIX, and one of the advantages of being listed on a major board like the NSDQ is the more regulated trading environment.
I agree that in the month to come there will be steady release of good news.
Those making a case about valuation should consider future potential of each of the drugs in the pipeline. Even with some delusion due to the need of financing the stock could be trading easily in the mid 20's by year end, and on a three year time frame around 160, if the company executes well. Do your own DD. I was skeptical first, but I did my DD and I'm very comfortable holding here.